Nutrien (NYSE:NTR - Get Free Report) had its price target raised by Barclays from $61.00 to $64.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an "equal weight" rating on the stock. Barclays's price target indicates a potential upside of 6.15% from the company's previous close.
Other equities analysts have also issued reports about the company. BNP Paribas upgraded Nutrien to a "strong-buy" rating in a research report on Wednesday, April 9th. Bank of America increased their price objective on Nutrien from $60.00 to $63.00 and gave the company a "buy" rating in a report on Wednesday, May 14th. Royal Bank Of Canada increased their price target on Nutrien from $60.00 to $65.00 and gave the company an "outperform" rating in a research note on Monday, May 12th. Morgan Stanley increased their price target on Nutrien from $60.00 to $65.00 and gave the company an "equal weight" rating in a research note on Thursday, June 26th. Finally, Berenberg Bank raised their price target on Nutrien from $54.00 to $59.00 and gave the stock a "buy" rating in a research report on Tuesday, April 15th. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating, seven have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $62.29.
Get Our Latest Research Report on Nutrien
Nutrien Trading Up 0.3%
NYSE:NTR traded up $0.15 on Monday, hitting $60.29. 432,551 shares of the stock were exchanged, compared to its average volume of 2,194,144. The stock has a market capitalization of $29.37 billion, a price-to-earnings ratio of 56.38, a P/E/G ratio of 1.14 and a beta of 0.80. Nutrien has a 52 week low of $43.70 and a 52 week high of $65.08. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.59 and a current ratio of 1.22. The company's 50-day moving average price is $58.95 and its 200 day moving average price is $53.38.
Nutrien (NYSE:NTR - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.35 by ($0.24). The firm had revenue of $4.67 billion for the quarter, compared to the consensus estimate of $5.16 billion. Nutrien had a return on equity of 6.08% and a net margin of 2.05%. The business's revenue for the quarter was down 5.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.46 earnings per share. On average, equities research analysts forecast that Nutrien will post 3.72 earnings per share for the current year.
Institutional Trading of Nutrien
Hedge funds and other institutional investors have recently modified their holdings of the business. Charles Schwab Investment Management Inc. raised its position in shares of Nutrien by 8.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,886,376 shares of the company's stock valued at $84,367,000 after purchasing an additional 144,025 shares during the period. Wealth Enhancement Advisory Services LLC raised its position in shares of Nutrien by 184.1% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 12,243 shares of the company's stock valued at $608,000 after purchasing an additional 7,934 shares during the period. Farther Finance Advisors LLC raised its position in shares of Nutrien by 27.6% in the first quarter. Farther Finance Advisors LLC now owns 4,627 shares of the company's stock valued at $229,000 after purchasing an additional 1,002 shares during the period. Wealthfront Advisers LLC bought a new stake in Nutrien during the 4th quarter worth approximately $556,000. Finally, Kingswood Wealth Advisors LLC purchased a new stake in Nutrien in the 1st quarter worth approximately $517,000. Institutional investors own 63.10% of the company's stock.
Nutrien Company Profile
(
Get Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.